BioCardia Inc.
BCDA | NASDAQ
$1.08
-$0.09 (-7.69%)
At close: Sep 21, 2026, 4:00 PM ET
$1.03
-$0.05 (-4.63%)
After-hours:
Sep 21, 2026, 7:55 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | 58K | 477K | 1.35M | 1.02M | 145K |
Cost of Revenue | 505K | 4.39M | 7.73M | 8.83M | 640K | 4K |
Gross Profit | -505K | -4.33M | -7.25M | -7.48M | 375K | 141K |
Operating Income | -8.28M | -8M | -11.64M | -11.9M | -12.63M | -15.53M |
Interest Income | n/a | n/a | n/a | n/a | 9K | 21K |
Pretax Income | -8.23M | -7.95M | -11.57M | -11.91M | -12.62M | -15M |
Net Income | -8.23M | -7.95M | -11.57M | -11.91M | -12.62M | -15M |
Selling & General & Admin | 3.32M | n/a | n/a | n/a | 5.09M | 5.86M |
Research & Development | 4.96M | 4.39M | 7.73M | 8.83M | 8.56M | 9.81M |
Other Expenses | -505K | -715K | -3.33M | -4.42M | -640K | n/a |
Operating Expenses | 7.77M | 3.67M | 4.4M | 4.42M | 13.01M | 15.67M |
Interest Expense | n/a | n/a | n/a | 6K | n/a | 3K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 8.28M | 8.06M | 12.12M | 13.25M | 13.65M | 15.67M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 6.67M | 2.74M | 1.41M | 1.18M | 1.13M | 674.58K |
Shares Outstanding (Diluted) | 6.67M | 2.74M | 1.41M | 1.18M | 1.13M | 674.58K |
EPS (Basic) | -1.23 | -2.90 | -8.19 | -10.05 | -11.19 | -22.20 |
EPS (Diluted) | -1.23 | -2.90 | -8.19 | -10.05 | -11.19 | -22.20 |
EBITDA | -7.72M | -7.88M | -11.49M | -11.82M | -12.57M | -14.44M |
EBIT | -8.23M | -7.95M | -11.57M | -11.9M | -12.63M | -15M |
Depreciation & Amortization | 505K | 67K | 84K | 82K | 60K | 566K |
Add to Watchlist
Select watchlists to add or remove BCDA